Form 4 for GILD Gilead Sciences
Accepted 2026-01-05 00:00:00 ET · period of report 2026-01-02 · accession 0001739515-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-05 | 2026-01-02 | GILD | Berger Dietmar | Chief Medical Off | M - OptEx | — | +16.3K | 16.3K | New | — |
| D | 2026-01-05 | 2026-01-02 | GILD | Berger Dietmar | Chief Medical Off | F - Tax | $121.60 | -6,944 | 9,382 | -43% | -$844.4K |
| D | 2026-01-05 | 2026-01-02 | GILD | Berger Dietmar | Chief Medical Off | M - OptEx | — | -16.3K | 41.2K | -28% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-02 | M | A | 16,326 | — | 16,326 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 2 | Common | Common Stock | 2026-01-02 | F | D | 6,944 | $121.60 | 9,382 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2026-01-02 | M | D | 16,326 | — | 41,179 | D | — · — to — | 16,326 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units vest in approximately three equal installments on the first three anniversaries of the date of grant until fully vested. |